Your browser is no longer supported. Please, upgrade your browser.
Settings
ADMP Adamis Pharmaceuticals Corporation daily Stock Chart
ADMP [NASD]
Adamis Pharmaceuticals Corporation
Index- P/E- EPS (ttm)-0.83 Insider Own3.20% Shs Outstand61.48M Perf Week-10.19%
Market Cap35.04M Forward P/E- EPS next Y-0.27 Insider Trans-0.93% Shs Float60.53M Perf Month-25.49%
Income-38.30M PEG- EPS next Q-0.10 Inst Own19.50% Short Float6.79% Perf Quarter-55.12%
Sales18.70M P/S1.87 EPS this Y-75.40% Inst Trans60.37% Short Ratio5.14 Perf Half Y-70.16%
Book/sh0.71 P/B0.80 EPS next Y48.10% ROA-67.10% Target Price3.37 Perf Year-79.57%
Cash/sh0.07 P/C8.55 EPS next 5Y- ROE-86.00% 52W Range0.48 - 3.29 Perf YTD-74.67%
Dividend- P/FCF- EPS past 5Y2.10% ROI-79.30% 52W High-82.31% Beta1.41
Dividend %- Quick Ratio0.80 Sales past 5Y- Gross Margin32.30% 52W Low21.25% ATR0.07
Employees152 Current Ratio1.00 Sales Q/Q48.70% Oper. Margin- RSI (14)32.83 Volatility17.22% 9.97%
OptionableYes Debt/Eq0.07 EPS Q/Q44.00% Profit Margin- Rel Volume2.23 Prev Close0.57
ShortableYes LT Debt/Eq0.00 EarningsNov 07 AMC Payout- Avg Volume800.47K Price0.58
Recom2.30 SMA20-12.33% SMA50-29.52% SMA200-66.83% Volume158,995 Change2.11%
Jul-16-19Downgrade B. Riley FBR Neutral → Sell $1.90 → $1.10
Nov-12-18Downgrade B. Riley FBR Buy → Neutral $7.50 → $2.50
May-11-18Reiterated Maxim Group Buy $5 → $10
Mar-23-18Reiterated B. Riley FBR, Inc. Buy $6.25 → $7.50
Dec-05-17Reiterated Maxim Group Buy $13 → $14
Oct-04-17Resumed B. Riley & Co. Buy $9.50
Jul-21-16Reiterated Maxim Group Buy $17 → $10
Dec-01-15Initiated Maxim Group Buy $16
May-29-15Initiated Mizuho Buy $10
Jan-28-14Initiated CRT Capital Buy $15
Oct-08-19 09:00AM  Adamis Pharmaceuticals Announces Presentation of ZIMHI data at IHV Scientific Meeting GlobeNewswire
Oct-01-19 09:00AM  Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI® in Australia and New Zealand GlobeNewswire
Sep-26-19 09:00AM  Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meeting GlobeNewswire
Sep-12-19 06:20AM  Adamis Pharmaceuticals Corporation (NASDAQ:ADMP): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St. -5.44%
Sep-03-19 09:00AM  Adamis Pharmaceuticals Provides Update for Naloxone Product Candidate GlobeNewswire -10.54%
Aug-28-19 09:00AM  Adamis Pharmaceuticals Provides Launch and Marketing Update for SYMJEPI GlobeNewswire
Aug-26-19 04:05PM  Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors GlobeNewswire
Aug-19-19 08:48AM  Edited Transcript of ADMP earnings conference call or presentation 8-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-14-19 09:00AM  Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding Subsidiary GlobeNewswire -6.09%
Aug-08-19 08:40PM  Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:30PM  Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update GlobeNewswire
Aug-07-19 06:38AM  Did Changing Sentiment Drive Adamis Pharmaceuticals's (NASDAQ:ADMP) Share Price Down A Painful 73%? Simply Wall St.
Aug-05-19 09:00AM  Adamis Pharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update GlobeNewswire
Aug-02-19 10:30AM  Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Aug-01-19 09:00AM  Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants GlobeNewswire -13.91%
Jul-31-19 04:05PM  Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
Jul-26-19 09:13AM  Will Flagship Impella Drive ABIOMED's (ABMD) Q1 Earnings? Zacks
09:12AM  Masimo (MASI) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-25-19 07:37AM  What's in the Offing for DexCom's (DXCM) Earnings in Q2? Zacks
Jul-24-19 09:00AM  Adamis Pharmaceuticals Provides Update on Litigation with Belcher Pharmaceuticals GlobeNewswire +10.81%
Jul-18-19 01:52PM  Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc. GlobeNewswire
Jul-09-19 08:30AM  Adamis Pharmaceuticals Provides Update on U.S. Retail Launch of SYMJEPI GlobeNewswire +10.85%
07:45AM  Novartis launches Adamis allergy shots in U.S. pharmacies amid EpiPen shortage Reuters
Jun-27-19 09:00AM  Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc. GlobeNewswire
Jun-20-19 10:02AM  Have Insiders Been Selling Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Shares? Simply Wall St.
Jun-11-19 09:00AM  Adamis Pharmaceuticals Provides Update on Its Higher Dose Naloxone Injection Product GlobeNewswire
May-21-19 08:30AM  Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection Product GlobeNewswire -12.09%
May-14-19 09:00AM  Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone Product GlobeNewswire
May-13-19 09:06PM  Edited Transcript of ADMP earnings conference call or presentation 9-May-19 9:00pm GMT Thomson Reuters StreetEvents -5.10%
May-09-19 05:55PM  Adamis Pharmaceuticals (ADMP) Reports Q1 Loss, Misses Revenue Estimates Zacks
04:51PM  Adamis: 1Q Earnings Snapshot Associated Press
04:30PM  Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update GlobeNewswire
May-07-19 09:00AM  Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update GlobeNewswire
May-02-19 10:32AM  Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Mar-15-19 04:39PM  Adamis Pharmaceuticals Announces 2018 Financial Results and Provides Business Update GlobeNewswire
07:39AM  The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA Benzinga
Mar-14-19 04:55PM  Adamis Pharmaceuticals Announces FDA Acceptance for Review of the New Drug Application of Its Higher Dose Naloxone Injection Product Candidate Business Wire
10:30AM  Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks
Mar-13-19 11:51AM  Before You Buy Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Consider Its Volatility Simply Wall St.
Feb-27-19 08:13AM  The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings Benzinga
Feb-26-19 06:54PM  Adamis Provides Regulatory Update on Sublingual Tadalafil GlobeNewswire
Feb-20-19 09:00AM  Adamis Pharmaceuticals Publishes the Rationale for a Higher Dose Naloxone Product to Counter the Current Opioid Epidemic GlobeNewswire
Jan-23-19 01:51PM  Is Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Excessively Paying Its CEO? Simply Wall St.
Jan-17-19 08:06AM  The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US Benzinga +9.51%
07:55AM  Today's Research Reports on Trending Tickers: Adamis Pharmaceuticals and Biocept ACCESSWIRE
Jan-16-19 04:48PM  Adamis stock surges on release of EpiPen alternative MarketWatch
04:18PM  Adamis Commercial Partner Launches SYMJEPI (epinephrine) in the US GlobeNewswire
Jan-03-19 07:30AM  Detailed Research: Economic Perspectives on Biohaven Pharmaceutical Holding, Air Transport Services Group, Pattern Energy Group, First Solar, Limelight Networks, and Adamis Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-02-19 10:21AM  Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James Benzinga +6.22%
Dec-31-18 04:02PM  Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe GlobeNewswire +7.14%
08:59AM  4 Pharma Stocks Gaining Speed on Monday (12/31/18) ACCESSWIRE
Dec-28-18 07:46PM  Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet GlobeNewswire
Dec-21-18 08:53AM  Adamis Pharmaceuticals (ADMP) Jumps: Stock Rises 5.3% Zacks -6.69%
Dec-17-18 09:00AM  Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options Zacks -7.47%
Dec-06-18 07:19PM  Novartis to launch Adamis' EpiPen rival in U.S. next year Reuters
09:30AM  Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI GlobeNewswire
Nov-28-18 08:39AM  Teva (TEVA) Launches First Generic Version of Mylan's EpiPen Zacks
Nov-09-18 06:00PM  Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:54PM  Adamis: 3Q Earnings Snapshot Associated Press
04:46PM  Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business Update GlobeNewswire
Nov-06-18 10:30AM  Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-09-18 07:50AM  Report: Developing Opportunities within Adamis Pharmaceuticals, Cass Information, Celldex Therapeutics, Par Pacific, Inovio Pharmaceuticals, and Liberty Global Future Expectations, Projections Moving into 2018 GlobeNewswire
Oct-04-18 11:14AM  Could Adamis Pharmaceuticals Corporations (NASDAQ:ADMP) Investor Composition Impacts Your Returns? Simply Wall St.
Sep-27-18 04:05PM  Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product GlobeNewswire
08:35AM  Adamis Pharmaceuticals (ADMP) in Focus: Stock Moves 8% Higher Zacks
Sep-26-18 08:15AM  Adamis Pharmaceuticals, FDA PDUFA Action Anticipated, Analyst Coverage ACCESSWIRE +8.00%
Sep-25-18 08:57AM  Options Traders Expect Huge Moves in Adamis Pharmaceuticals (ADMP) Stock Zacks +7.14%
08:37AM  Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options Zacks
Aug-27-18 12:02PM  Adamis Pharmaceuticals Provides Business Update GlobeNewswire
Aug-17-18 09:25AM  Teva Gets FDA Nod for First Generic Version of Mylan's EpiPen Zacks -13.27%
08:00AM  Todays Research Reports on Stocks to Watch: Antares Pharma and Adamis Pharmaceuticals ACCESSWIRE
Aug-16-18 01:25PM  FDA approves first rival generic EpiPen, sending Teva shares up 6% MarketWatch -16.91%
Aug-10-18 10:15AM  Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates Zacks
09:09AM  Adamis: 2Q Earnings Snapshot Associated Press
09:00AM  Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update GlobeNewswire
Aug-06-18 04:05PM  Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full GlobeNewswire +6.25%
Aug-02-18 09:00AM  Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire -6.06%
Aug-01-18 04:03PM  Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
08:30AM  Market Trends Toward New Normal in Horizon Global, Bio-Techne, Adamis Pharmaceuticals, Kadant, Semgroup, and Provident Financial Services Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-23-18 09:00AM  Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline GlobeNewswire
Jul-06-18 09:16AM  Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs Zacks
Jul-03-18 08:41AM  Adamis (ADMP) Surges Following Novartis Deal for Symjepi Zacks -6.25%
08:00AM  Today's Research Reports on Stocks to Watch: Adamis Pharmaceuticals and MiMedx ACCESSWIRE
06:51AM  Adamis has a partner to market its EpiPen competitor after a year-long search MarketWatch
Jul-02-18 07:46PM  [$$] Novartis Injects Itself Into Planned Rollout of EpiPen Competitor The Wall Street Journal +50.00%
05:30PM  [$$] Novartis Injects Itself Into Planned Rollout of EpiPen Rival The Wall Street Journal
11:04AM  Adamis Pharma Shares Soar on Deal With Novartis for Epipen Competitor TheStreet.com
10:06AM  Why Adamis (ADMP) Is Skyrocketing Today SmarterAnalyst
Jul-01-18 08:00PM  Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement for Symjepi GlobeNewswire
Jun-28-18 07:50AM  Complimentary Technical Snapshots on Valeant Pharmaceuticals International and Three More Healthcare Stocks ACCESSWIRE
Jun-01-18 09:00AM  Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options Zacks
May-18-18 08:37AM  Options Traders Expect Huge Moves in Adamis Pharmaceuticals (ADMP) Stock Zacks +8.05%
May-10-18 06:30PM  Adamis: 1Q Earnings Snapshot Associated Press
05:51PM  Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update GlobeNewswire
Apr-23-18 08:43AM  Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options Zacks
Apr-22-18 12:02PM  High Growth Stocks To Invest In Simply Wall St.
Apr-19-18 08:25AM  Recent Analysis Shows J.Jill, BankUnited, Toronto Dominion Bank, Adamis Pharmaceuticals, BioDelivery Sciences International, and First Solar Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Apr-10-18 08:43AM  What Falling Estimates & Price Mean for Adamis Pharmaceuticals (ADMP) Zacks
Mar-15-18 05:59PM  Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update GlobeNewswire
Mar-08-18 09:00AM  Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi Epinephrine Prefilled Syringe to the Market Leading Product in the Annals of Allergy, Asthma and Immunology GlobeNewswire
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of albuterol (APC-2000) for the treatment of bronchospasms; fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARLO DENNIS J PHDPresident & CEOAug 19Sale1.0610,47711,117353,930Aug 21 06:34 PM
Hopkins Robert OChief Financial OfficerAug 19Sale1.067,1017,536333,247Aug 21 06:33 PM
Daniels Karen K.VP of OperationsAug 19Sale1.065,2435,558169,110Aug 21 06:32 PM
Marguglio David J.SVP and Chief Business OfficerAug 19Sale1.108,1098,883373,590Aug 21 06:30 PM
Moss Ronald B.Chief Medical OfficerAug 19Sale1.068,3838,893267,872Aug 21 06:26 PM
WILLIAMS RICHARD CDirectorMay 24Buy1.5750,00078,520239,918May 28 06:12 PM
DENBY WILLIAM CDirectorMay 24Buy1.606,2509,997108,750May 28 06:13 PM
ROTHERMEL ROBERT BDirectorMay 24Buy1.586,50010,270133,500May 28 06:11 PM
CARLO DENNIS J PHDPresident & CEOMay 20Sale1.7311,18419,339364,407May 22 05:20 PM
Daniels Karen K.VP of OperationsMay 20Sale1.735,5919,670174,353May 22 05:19 PM
Moss Ronald B.Chief Medical OfficerMay 20Sale1.778,74115,464276,255May 22 05:16 PM
Hopkins Robert OChief Financial OfficerMay 20Sale1.737,55913,109340,348May 22 05:14 PM
Marguglio David J.SVP and Chief Business OfficerMay 20Sale1.778,73515,464381,699May 22 05:15 PM
Moss Ronald B.Chief Medical OfficerMar 20Sale2.276,64715,075284,996Mar 22 06:03 PM
Daniels Karen K.VP of OperationsMar 20Sale2.3013,91132,011179,944Mar 22 06:00 PM
CARLO DENNIS J PHDPresident & CEOMar 20Sale2.2713,29230,13342,353Mar 22 05:59 PM
Hopkins Robert OChief Financial OfficerMar 20Sale2.308,90020,446347,907Mar 22 05:58 PM
Marguglio David J.SVP and Chief Business OfficerMar 20Sale2.2810,57924,107390,434Mar 22 05:55 PM